Skip to main content
. 2017 Mar 17;8(35):59810–59822. doi: 10.18632/oncotarget.16336

Table 2. Tumor responses (N = 67).

Responses No. of patients %
CR 0 0
PR 6 9.0
SD 44 65.7
PD 17 25.4
ORR(%) 9.0 (95%CI, 2.0-16.0)
CBR(%) 38.8 (95%CI 26.8-50.8)

Abbreviations: CR, complete response; PR, partial response; SD, stable disease; PD, progression disease; ORR, objective response rate; CBR, clinical benefit rate